Trump’s Drug Pricing Executive Order, Explained (Again)
Recycled, blocked, performative—and now, back from the grave for a second act of failure.
Next week, President Donald Trump is expected to sign a new executive order to lower prescription drug prices for Medicare recipients. The order, which revives the so-called “Most Favored Nation” model, would peg the cost of certain medications to what other wealthy nations pay. Administration officials are calling it bold. They say it delivers on Trump…
Keep reading with a 7-day free trial
Subscribe to The Coffman Chronicle to keep reading this post and get 7 days of free access to the full post archives.
 | A guest post by
|